Skip to main content
Watch Insiders
TNXP filings

Corporate insider profile

Seth Lederman Filing Activity

Latest reported as Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP).

Purchase filings
3
Reported companies
1
Net open-market value
$309,880
Latest transaction
Aug 27, 2026

Affiliated corporations

Reported company relationships

TNXPLatest reported

Tonix Pharmaceuticals Holding Corp.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 27, 2026Tonix Pharmaceuticals Holding Corp. (TNXP)Chief Executive OfficerOpen Market Purchase2,000$13.79$27,580
Jun 9, 2026Tonix Pharmaceuticals Holding Corp. (TNXP)Chief Executive OfficerOpen Market Purchase5,000$11.79$58,950
Mar 18, 2026Tonix Pharmaceuticals Holding Corp. (TNXP)Chief Executive OfficerOpen Market Purchase15,000$14.89$223,350